Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…
DTX Group Debuts as Global Force, Powered by Strategic Vision and Independence Under Hussein Lookmanjee’s Leadership
Backed by years of preparation and a clear global strategy, DTX Group…
